SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1331Amgen wins a minor round against Ortho in the discounting/bundling suit: >&gtuck-11/22/2006
1330The system is the patient. <i>The findings reinforce mounting concerns thkeokalani'nui-11/16/2006
1329Heart Risk Seen in Drug for Anemia [NYT] By ALEX BERENSON November 16, 2006 A Doc Bones-11/16/2006
1328citi: AMGN: Roche's New Lines of Defense Unlikely to Weaken Amgen's Posimopgcw-11/14/2006
1327ENBREL is the First Biologic to Publish Data Showing Safety and Sustained Efficamopgcw-11/13/2006
1326>>although it is difficult to compare results across trials<< Amen nigel bates-11/6/2006
1325I'll see you and raise you one Merrill: AMG-706 data relatively disappointitom pope-11/6/2006
1324AMG 706 Shows Activity in Phase 2 Study of Patients with Advanced Imatinib-Resisnigel bates-11/5/2006
1323Neupogen/Neulasta knockoffs will arrive too at some point.DewDiligence_on_SI-11/3/2006
1322Diagnosing Amgen Kerry A. Dolan, 10.25.06, 5:00 PM ET Chief Executive Kevin Shamopgcw-11/3/2006
1321<i>Typo, I guess, but what should it be? Just change the 6s to 7s?</i&gDewDiligence_on_SI-10/24/2006
1320>>We expect Vectibix data in front-line colorectal cancer in 1Q06 (responstuck-10/24/2006
1319Merrill Solid 3Q; Raising Estimates Amgen reported in-line revenues & operatom pope-10/24/2006
1318Amgen Lifts Full-Year Outlook After 14% Rise in Quarter's Net [WSJ] By DAVIDoc Bones-10/24/2006
1317Amgen handily beats estimates, posting EPS numbers above the highest estimate, wtuck-10/23/2006
1316AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP James B. Bussel,zeta1961-10/22/2006
1315Full court press against Roche. Might be overkill, but it is Amgen's franchtuck-10/20/2006
1314got to hand it to them, interesting move indeed..here is citi's take: OPINImopgcw-10/20/2006
1313your timing is impeccable: AMGN: Judge Young Issues Order Expediting Trial mopgcw-10/20/2006
1312Fantastic! Remove the market from the competition! Don't know what it willsteve kammerer-10/19/2006
1311citi: OPINION Today, Amgen's stock has been under pressure, which we beliemopgcw-10/17/2006
1310gs: Amgen Inc. (AMGN): Minor setback from FDA delay on Aranesp for predialysis mopgcw-10/17/2006
1309gs: Amgen Inc. (AMGN): Incremental data on Aranesp & competition at ASN 52-mopgcw-10/17/2006
1308AMGN gets approvable on two week & monthly dosing for CKD patients not on dituck-10/14/2006
1307>>Anyone know what happened to AMG-108 (anti IL1) ?<< You remember tuck-10/11/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News